IP Library Granted Patent US 9,605,297
Granted Patent B2
US 9,605,297 · App. 15/029,519 · Granted Mar 28, 2017

Method of generating linkage-specific di-and polyprotein probes

Inventors: Zhihao Zhuang (Wilmington, DE); Guorui Li (Baltimore, MD)
Assignee: UNIVERSITY OF DELAWARE
C12Q1/37C07D317/28C07K1/10C07K14/47C07K2319/50C07K2319/95G01N2333/95G01N2440/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,605,297
App. No.
15/029,519
Granted
Mar 28, 2017
Kind
B2
Abstract

Deubiquitinating enzyme (DUB) probes are provided that resemble native diubiquitin (diUB) with a similar linkage size and that may contain a Michael acceptor for trapping the DUB active-site cysteine. For example, both K63- and K48-linked diubiquitin probes are generated using a facile chemical ligation method, utilizing the linker compound 3-(2-(bromomethyl)-1,3-dioxolan-2-yl)prop-2-en-1-amine. The diUb probes are capable of labelling DUBs from different families and may be employed to reveal intrinsic linkage specificities of DUBs.

Claims (31)

1. A compound having a structure in accordance with Formula (I):

H 2 NCH 2 —R—C(Diox)CH 2 X   (I)

wherein R is —CH 2 CH 2 — or —CH═CH—, Diox is —O(CH 2 ) n O— with n=2 or 3 and forms a 1,3-dioxolane ring or 1,3-dioxane ring which includes the carbon atom to which the oxygen atoms of —O(CH 2 ) n O— are both bonded, and X is Br, Cl or I.

2. The compound of claim 1 , wherein R is —CH═CH—, n=2, and X is Br.

3. The compound of claim 1 , wherein R is —CH 2 CH 2 —, n=2, and X is Br.

4. A method of making the compound of claim 1 , comprising hydrolyzing a precursor compound having a structure in accordance with Formula (II):

(Isoindol)CH 2 —R—C(Diox)CH 2 X   (II)

wherein Isoindol is an isoindoline-1,3-dione moiety, R is —CH 2 CH 2 — or —CH═CH—, and Diox is —O(CH 2 ) n O— with n=2 or 3 and forms a 1,3-dioxolane ring or 1,3-dioxane ring which includes the carbon atom to which the oxygen atoms of —O(CH 2 ) n O— are both bonded, and X is Br, Cl or I.

5. The method of claim 4 , wherein the precursor compound has been prepared by reacting a compound having a structure in accordance with Formula (III):

(Isoindol)CH 2 —R—C(═O)CH 2 X   (III)

with ethylene glycol or 1,3-propanediol.

6. A method of making a di- or polyprotein, comprising linking a first polypeptide molecule and a second polypeptide molecule using a compound having a structure in accordance with Formula (I):

H 2 NCH 2 —R—C(Diox)CH 2 X   (I)

wherein R is —CH 2 CH 2 — or —CH═CH—, Diox is —O(CH 2 ) n O— with n=2 or 3 and forms a 1,3-dioxolane ring or 1,3-dioxane ring which includes the carbon atom to which the oxygen atoms of —O(CH 2 ) n O— are both bonded, and X is Br, Cl or I.

7. The method of claim 6 , wherein the first polypeptide molecule is Ub 1-75 .

8. The method of claim 6 , wherein the second polypeptide molecule contains a cysteine residue.

9. The method of claim 6 , wherein the second polypeptide molecule is a ubiquitin having a cysteine residue at position 6, 11, 27, 29, 33, 48 or 63.

10. A method of making a di- or polyprotein, comprising the steps of:

a) reacting PP1-C(═O)—S—R 1 , wherein PP1 is a first polypeptide and —C(═O)—S—R 1 is a thioester group, with a compound having a structure in accordance with Formula (I):

H 2 NCH 2 —R—C(Diox)CH 2 X   (I)

wherein R is —CH 2 CH 2 — or —CH═CH—, Diox is —O(CH 2 ) n O— with n=2 or 3 and forms a 1,3-dioxolane ring or 1,3-dioxane ring which includes the carbon atom to which the oxygen atoms of —O(CH 2 ) n O— are both bonded, and X is Br, Cl or I to provide PP1-C(═O)NHCH 2 —R—C(Diox)CH 2 X;

b) converting the 1,3-dioxolane ring or 1,3-dioxane ring to a ketone to provide PP1-C(═O)NH—CH 2 —R—C(═O)CH 2 X; and

c) reacting the PP1-C(═O)NH—CH 2 —R—C(═O)CH 2 X with a second polypeptide bearing a cysteine residue.

11. The method of claim 10 , wherein the second polypeptide is a ubiquitin and the cysteine residue is present at the 6, 11, 27, 29, 33, 48 or 63 position of the ubiquitin.

12. The method of claim 10 , wherein the second polypeptide bears a reporter tag.

13. The method of claim 12 , wherein the reporter tag is selected from the group consisting of affinity tags, biotin and fluorophores.

14. The method of claim 12 , wherein the reporter tag is an affinity tag selected from the group consisting of HA-tag, His-tag, FLAG-tag, and Myc-tag.

15. The method of claim 10 , wherein the first polypeptide is a ubiquitin.

16. The method of claim 10 , wherein the first polypeptide is Ub 1-75 .

17. The method of claim 10 , wherein R is —CH 2 CH 2 —, n=2, and X is Br.

18. The method of claim 10 , wherein R is —CH═CH—, n=2 and X is Br.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 25, 2017
From: UNIVERSITY OF DELAWARE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042571/0748 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2016
From: ZHUANG, ZHIHAO; LI, GUORUI
To: UNIVERSITY OF DELAWARE
Reel/Frame 038291/0457 →
Continuity (2)
Provisional Application 61891571 · Oct 16, 2013
Related Publication 20160237471A1 · Aug 18, 2016